Complement activation plays a key role in the side-effects of rituximab treatment. [electronic resource]
Producer: 20020306Description: 807-11 p. digitalISSN:- 0007-1048
- Adult
- Aged
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- adverse effects
- Complement Activation
- Complement C3b -- analysis
- Complement C3c -- analysis
- Complement C4 -- analysis
- Complement C4b -- analysis
- Cytokines -- blood
- Female
- Humans
- Interleukin-6 -- blood
- Interleukin-8 -- blood
- Lymphocyte Count
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Peptide Fragments
- Rituximab
- Stimulation, Chemical
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.